Exciting! Our COVID-19 vaccine has been updated on @WHO list of candidate vaccines to highlight our proprietary and novel msDNA-VLP vaccine technology. Check it on page 2, here-->
https://t.co/wEGii4g9aV
#MediphageBioceuticals#COVIDー19#COVID19vaccine
A safe, redosable and effective gene expression system with proprietary efficient and scalable manufacturing capabilities. That's our msDNA platform technology!
For full length video, check here: https://t.co/WEIJW8wxdq
#Mediphagebioceuticals#msDNA#genetherapy
Mediphage was one of over 30 of Canada's most promising #innovative health science companies to attend the 2019 Niagara Investment Summit. Thank you @OBIOscience for the great opportunity!
MATTER and Consulate General of Canada collaborate to help Canadian life science entrepreneurs enter U.S. market through its C2MP, a @SDC_TCS initiative https://t.co/S0BnPSIbOF
Mediphage has been selected as one of the top 30 RESI #Innovation Challenge startup applicants who will be participating in the poster presentation showcase at the third annual RESI conference!
Out of 208 teams, Mediphage was selected to be one of 20 finalists in the Toronto Division for the 2nd China (Shenzhen) Innovation & Entrepreneurship International Competition. Mediphage looks forward to pitching on March 24th @JLabs for 1 of 10 finalist spots to pitch in China.
Our very own Director of Advancement, Lee Bowman, pitched Mediphage's msDNA to the Belgian Royal Family last week and received a positive response from the queen with our work!
Our CEO, Roderick Slavcev, will be sharing Mediphage's healthcare technology journey from academia into commercialization on April 12th @JLABS! Don't miss out and get your ticket today at https://t.co/BSuIvuRIZw